Clinical Trial Update: Duration of Analgesia With Dexmedetomidine and Ropivacaine in Brachial Plexus Block [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating duration of analgesia with dexmedetomidine and ropivacaine in brachial plexus block was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Analgesia
• Pain
• Peripheral Nerve Block

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)
• Ropivacaine (Ropivacaine)

Snippet

Sponsor: University of Florida | Conditions: Analgesia, Pain, Acute | Phase 4 | Status: WITHDRAWN